Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Genus plc

Market Cap 1.45B 1.95B 1.68B 1.55B 2.72B 185B 2.76B 18.32B 7.14B 90.18B 7.32B 7.16B 312B P/E Ratio 2026 *
13.1x
P/E Ratio 2027 * 26.7x
Enterprise Value 1.56B 2.1B 1.81B 1.67B 2.93B 199B 2.97B 19.7B 7.68B 97B 7.87B 7.7B 336B EV / Sales 2026 *
2.31x
EV / Sales 2027 * 2.29x
Free-Float
99.2%
Yield 2026 *
1.6%
Yield 2027 * 1.65%
1 day+0.29%
1 month-1.38%
3 months-16.60%
6 months-11.62%
Current year-11.24%
1 month 31.06
Extreme 31.065
31.06
Current year 30.98
Extreme 30.975
37.25
1 year 26.01
Extreme 26.01
37.25
3 years 20.51
Extreme 20.51
37.25
5 years 20.51
Extreme 20.51
75
10 years 19.64
Extreme 19.64
77
Manager TitleAgeSince
Chief Executive Officer 57 2023-06-30
Director of Finance/CFO - 2025-07-31
Chief Operating Officer - 2010-12-31
Director TitleAgeSince
Director/Board Member 62 2016-03-31
Director/Board Member 73 2018-05-31
Chairman 69 2020-11-24
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%-.--% - - 1.94B
-0.35%-0.22%-15.03%-12.88% 42.96B
+3.11%+3.11%+274.29%+507.94% 31.73B
+0.22%-1.08%+14.03%-14.37% 30.22B
+1.62%-2.08%-4.36%+24.05% 28.94B
+4.09%-1.98%+11.99%+17.37% 23.87B
-1.63%+2.88%+53.73%+114.36% 13.57B
-0.40%-1.48%+7.48%+7.12% 12.96B
+1.14%+3.62% - - 13.39B
-0.74%-1.62%+105.71%+76.01% 12.2B
Average +0.60%-0.71%+55.98%+89.95% 23.31B
Weighted average by Cap. +0.79%-1.08%+54.76%+95.75%

Financials

2026 *2027 *
Net sales 676M 907M 784M 722M 1.27B 86.25B 1.29B 8.53B 3.33B 41.98B 3.41B 3.33B 145B 666M 894M 772M 711M 1.25B 84.97B 1.27B 8.4B 3.28B 41.36B 3.35B 3.28B 143B
Net income 126M 169M 146M 134M 236M 16.03B 239M 1.59B 618M 7.8B 633M 620M 27.02B 55.86M 74.98M 64.76M 59.67M 105M 7.13B 106M 705M 275M 3.47B 281M 275M 12.01B
Net Debt 110M 147M 127M 117M 206M 14B 209M 1.38B 540M 6.81B 553M 541M 23.59B 70.69M 94.89M 81.95M 75.52M 132M 9.02B 135M 892M 348M 4.39B 356M 349M 15.2B
Logo Genus plc
Genus plc is a United Kingdom-based global animal genetics company. The Company is advancing animal breeding and genetic improvement by applying biotechnology and selling added value products to livestock farming and food producers. It focuses on the dairy, beef and pork food production sectors, through two businesses: ABS (bovine genetics) and PIC (porcine genetics). Its segments include Genus PIC, Genus ABS and Genus Research and Development. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. Its porcine and bovine divisions operate under the brand names PIC and ABS. It operates in 30 countries, across six continents, and reaches a further 50 markets through distribution partners.
Employees
3,190
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
21.70GBP
Average target price
31.28GBP
Spread / Average Target
+44.16%

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!